Search results
Showing results for
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.
Conference paper
Gagnon LL. et al, (2026), Leukemia
Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.
Journal article
Weight CM. et al, (2026), J Infect Dis
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.
Journal article
Turan G. et al, (2026), Vaccines (Basel), 14
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
Journal article
Bijukchhe SM. et al, (2026), Lancet Infect Dis
Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.
Journal article
Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37
Human-specific features of the cerebellum and ZP2-regulated synapse development.
Journal article
Kim S-K. et al, (2026), Cell
Predicting how perturbations reshape cellular trajectories with PerturbGen
Preprint
Chi Hao Ly K. et al, (2026)
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.
Journal article
Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10
Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.
Journal article
Alam N. et al, (2026), EMBO Mol Med
CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review.
Journal article
Fusani L. et al, (2026), Rev Med Virol, 36
Broad lessons from negative trials in rare diseases.
Journal article
Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217
The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.
Journal article
Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235
Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge
Journal article
Reiné J. et al, (2026), BMJ Immunology, 1, e000012 - e000012
Securing the future of immunisation: ESCMID’s vision
Journal article
Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167
Systems vaccinology analysis of saRNA immunization identifies an acute innate immune signature correlated with adaptive immunity
Journal article
Elliott T. et al, (2026), 34
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.
Journal article
O'Hagan S. et al, (2026), Arch Dis Child
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.
Journal article
Kudowa E. et al, (2026), NPJ Vaccines
Safety and Efficacy of Intraventricular Antibiotics for Central Nervous System Infections in Children: A Single-center Observational Study.
Journal article
Almarzooqi M. et al, (2026), Pediatr Infect Dis J
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.
Journal article
Dold C. et al, (2026), Mol Ther